I agree 100%. It's always bothered me talking about uplisting without revenue. I believe that when a company proves that it can deliver a product to market and has a source of income then investors are more willing to invest.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links
